Solpadeine Explained

Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, made by Omega Pharma.^[1] The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.^[2]

In the United Kingdom there are four different medicines using the Solpadeine name, with no common active ingredient between them. The range includes:

• Solpadeine Headache, containing paracetamol with caffeine
• Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
• Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus)
• Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine

In 2016 it was one of the biggest selling branded over-the-counter medications sold in Great Britain, with sales of £43.1 million.^[3]

In Australia it is marketed as Panadeine.^[4]

External links

• Solpadeine Website

Notes and References

1. Web site: Omega Pharma - Solpadeine . Omega-pharma.pl . 2013-09-14.
2. Web site: Corporate Comms . GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands . Us.gsk.com . 2012-03-15 . 2013-09-14.
3. News: A breakdown of the over-the-counter medicines market in Britain in 2016. Pharmaceutical Journal. 28 April 2017 . 18 March 2020 .
4. Web site: Panadeine - GlaxoSmithKline New Zealand . Gsk.co.nz . 2008-11-17 . 2013-09-14.